Cargando…
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience
BACKGROUND: To report Taiwan’s experience in robot-assisted laparoscopic nephroureterectomy (RANU) for upper tract urothelial carcinoma (UTUC). METHODS: Twenty patients with a diagnosis of renal pelvic or ureteral urothelial carcinoma underwent RANU at three medical centers. We performed RANU by re-...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118608/ https://www.ncbi.nlm.nih.gov/pubmed/25031072 http://dx.doi.org/10.1186/1477-7819-12-219 |
_version_ | 1782328867005923328 |
---|---|
author | Yang, Chen-Kuang Chung, Shiu-Dong Hung, Shun-Fa Wu, Wei-Che Ou, Yen-Chuan Huang, Chao-Yuan Pu, Yeong-Shiau |
author_facet | Yang, Chen-Kuang Chung, Shiu-Dong Hung, Shun-Fa Wu, Wei-Che Ou, Yen-Chuan Huang, Chao-Yuan Pu, Yeong-Shiau |
author_sort | Yang, Chen-Kuang |
collection | PubMed |
description | BACKGROUND: To report Taiwan’s experience in robot-assisted laparoscopic nephroureterectomy (RANU) for upper tract urothelial carcinoma (UTUC). METHODS: Twenty patients with a diagnosis of renal pelvic or ureteral urothelial carcinoma underwent RANU at three medical centers. We performed RANU by re-docking the robot after the nephrectomy with or without repositioning for excision of the distal ureter and bladder cuff. RESULTS: From November 2010 to July 2013, a total of 20 patients with a mean age of 70.1 +/- 9.9 years (range 43 to 92 years) and mean body mass index (BMI) of 22.9 +/-3.8 kg/m(2) underwent RANU for renal pelvic or ureteral urothelial carcinoma. Mean operative time was 251.6 +/- 126.7 minutes (range 110 to 540 minutes), estimated blood loss was 50.0 +/- 42.9 mL (range 10 to 200 mL), and mean length of hospital stay was 6.7 +/- 2.4 days (range 4 to 12 days). Pathology data revealed 19 high and one low-grade urothelial carcinoma and staged Ta for three, T1 for five, T2 for five and T3 for seven. With a mean follow-up of 14.7 months (range 2 to 34 months), three intravesical recurrences developed in the bladder, and four of them also developed metastatic disease. CONCLUSIONS: The TRUST early experience showed that RANU is a safe and feasible minimally invasive procedure for UTUC. |
format | Online Article Text |
id | pubmed-4118608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41186082014-08-02 Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience Yang, Chen-Kuang Chung, Shiu-Dong Hung, Shun-Fa Wu, Wei-Che Ou, Yen-Chuan Huang, Chao-Yuan Pu, Yeong-Shiau World J Surg Oncol Research BACKGROUND: To report Taiwan’s experience in robot-assisted laparoscopic nephroureterectomy (RANU) for upper tract urothelial carcinoma (UTUC). METHODS: Twenty patients with a diagnosis of renal pelvic or ureteral urothelial carcinoma underwent RANU at three medical centers. We performed RANU by re-docking the robot after the nephrectomy with or without repositioning for excision of the distal ureter and bladder cuff. RESULTS: From November 2010 to July 2013, a total of 20 patients with a mean age of 70.1 +/- 9.9 years (range 43 to 92 years) and mean body mass index (BMI) of 22.9 +/-3.8 kg/m(2) underwent RANU for renal pelvic or ureteral urothelial carcinoma. Mean operative time was 251.6 +/- 126.7 minutes (range 110 to 540 minutes), estimated blood loss was 50.0 +/- 42.9 mL (range 10 to 200 mL), and mean length of hospital stay was 6.7 +/- 2.4 days (range 4 to 12 days). Pathology data revealed 19 high and one low-grade urothelial carcinoma and staged Ta for three, T1 for five, T2 for five and T3 for seven. With a mean follow-up of 14.7 months (range 2 to 34 months), three intravesical recurrences developed in the bladder, and four of them also developed metastatic disease. CONCLUSIONS: The TRUST early experience showed that RANU is a safe and feasible minimally invasive procedure for UTUC. BioMed Central 2014-07-17 /pmc/articles/PMC4118608/ /pubmed/25031072 http://dx.doi.org/10.1186/1477-7819-12-219 Text en Copyright © 2014 Yang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yang, Chen-Kuang Chung, Shiu-Dong Hung, Shun-Fa Wu, Wei-Che Ou, Yen-Chuan Huang, Chao-Yuan Pu, Yeong-Shiau Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience |
title | Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience |
title_full | Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience |
title_fullStr | Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience |
title_full_unstemmed | Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience |
title_short | Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience |
title_sort | robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the taiwan robot urological surgery team (trust) experience |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118608/ https://www.ncbi.nlm.nih.gov/pubmed/25031072 http://dx.doi.org/10.1186/1477-7819-12-219 |
work_keys_str_mv | AT yangchenkuang robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience AT chungshiudong robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience AT hungshunfa robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience AT wuweiche robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience AT ouyenchuan robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience AT huangchaoyuan robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience AT puyeongshiau robotassistednephroureterectomyforuppertracturothelialcarcinomathetaiwanroboturologicalsurgeryteamtrustexperience |